A case of moyamoya disease symptomatized early after nivolumab initiation – Possible association between immune checkpoint inhibitors and moyamoya disease

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number106355
JournalClinical Neurology and Neurosurgery
Volume200
DOIs
Publication statusPublished - 2021 Jan

Keywords

  • Autoimmunity
  • Case report
  • Melanoma
  • Moyamoya disease
  • Nivolmab

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this